Fig. 4
From: Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor
a Intracellular ROS generation after different treatments visualized by CLSM. b Flow cytometry analysis of ROS generation after different treatments. c Cell viabilities of 4T1 cells after various treatments. d Flow cytometry analysis of apoptosis rates after receiving different treatments. e CLSM images of calcein AM/PI co-stained 4T1 cells after various treatments (live and dead cells are stained green and red, respectively)